Literature DB >> 29653367

Upregulation of lncRNA PlncRNA-1 indicates the poor prognosis and promotes glioma progression by activation of Notch signal pathway.

Xiaolong Wang1, Yungang Yan2, Chunman Zhang1, Wei Wei1, Xin Ai1, Yongbin Pang3, Ying Bian4.   

Abstract

Prostate cancer-up-regulated long noncoding RNA 1(PlncRNA-1) has been demonstrated to be increased in several cancers, which plays an oncogenic role in the development of cancer. However, the exact functions and molecular mechanism of PlncRNA-1 in the tumorigenesis of glioma has not been studied. In present work, we firstly identified that PlncRNA-1 expression levels were prominently augmented in glioma patient tissues and glioma cell lines compared with adjacent noncancerous tissue and normal cells, respectively. Moreover, Kaplan-Meier survival analysis indicated that glioma patients with high PlncRNA-1 expression had shorter overall survival (OS) and progression-free survival (PFS) than those with low PlncRNA-1 expression. Furthermore, loss-of-function assay showed that PlncRNA-1 knockdown dramatically reduced cell proliferation, colony formation, and promoted apoptosis of glioma cell lines. In addition, overexpression of PlncRNA-1 promoted cell proliferation, stimulated cell colony formation, and inhibited cell apoptosis in NHA cells. Mechanically, our results showed that PlncRNA-1 significantly promoted activation of the Notch signal pathway through regulation of Notch-1, Jag-1, and Hes-1 expression. Collectively, our results implied that lncRNA PlncRNA-1 may exert tumor-promoting role in the development and progression of glioma through modulation of Notch signal pathway, providing a candidate therapeutic target for patients with glioma.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Glioma; Notch signal pathway; PlncRNA-1; Prognosis; Progression

Mesh:

Substances:

Year:  2018        PMID: 29653367     DOI: 10.1016/j.biopha.2018.03.150

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.

Authors:  Zhe Liu; Hong Li; Sumeng Fan; Hui Lin; Wenwei Lian
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

2.  Hypoxia-induced lncHILAR promotes renal cancer metastasis via ceRNA for the miR-613/206/ 1-1-3p/Jagged-1/Notch/CXCR4 signaling pathway.

Authors:  Guanghui Hu; Junjie Ma; Jin Zhang; Yonghui Chen; Huan Liu; Yiran Huang; Junhua Zheng; Yunfei Xu; Wei Xue; Wei Zhai
Journal:  Mol Ther       Date:  2021-05-29       Impact factor: 12.910

3.  MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents.

Authors:  Bin Yang; Chunping Wang; Hui Xie; Yiwu Wang; Jiagan Huang; Yihui Rong; Huixin Zhang; Huifang Kong; Yongping Yang; Yinying Lu
Journal:  Cell Death Dis       Date:  2019-10-14       Impact factor: 8.469

4.  Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis.

Authors:  Weiting Kang; Qiang Wang; Yun Dai; Hanbo Wang; Muwen Wang; Jin Wang; Dong Zhang; Peng Sun; Taiguo Qi; Xunbo Jin; Zilian Cui
Journal:  Cell Death Dis       Date:  2020-12-07       Impact factor: 8.469

Review 5.  Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.

Authors:  Seyed Mojtaba Mousavi; Maryam Derakhshan; Fatereh Baharloii; Fatemeh Dashti; Seyed Mohammad Ali Mirazimi; Maryam Mahjoubin-Tehran; Saereh Hosseindoost; Pouya Goleij; Neda Rahimian; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-12-22       Impact factor: 7.200

6.  The nomogram based on the 6-lncRNA model can promote the prognosis prediction of patients with breast invasive carcinoma.

Authors:  Dankun Luo; Wenchao Yao; Qiang Wang; Qiu Yang; Xuxu Liu; Yang Yang; Weihui Zhang; Dongbo Xue; Biao Ma
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

Review 7.  Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer.

Authors:  Omnia Emam; Eman F Wasfey; Nadia M Hamdy
Journal:  Cancer Cell Int       Date:  2022-10-13       Impact factor: 6.429

Review 8.  Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.

Authors:  Giasemi C Eptaminitaki; Nora Wolff; Dimitris Stellas; Konstantinos Sifakis; Stavroula Baritaki
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.